First-line treatment of metastatic renal cell carcinoma in the immuno-oncology era: systematic review and network meta-analysis

FSM Monteiro, A Soares, M Debiasi, FA Schutz… - Clinical Genitourinary …, 2020 - Elsevier
Combination treatments with immuno-oncology (IO) agents and IO agents plus a vascular
endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) have been …
被引用次数：21 相关文章

First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

FSM Monteiro, A Soares… - Clinical …, 2020 - clinical-genitourinary-cancer.com
Combination treatments with immuno-oncology (IO) agents and IO agents plus a vascular
endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) have been …
[PDF] pucrs.br

[PDF][PDF] First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

FSM MONTEIRO, A SOARES, M DEBIASI… - Clinical Genitourinary …, 2020 - meriva.pucrs.br
Combination treatments with immuno-oncology (IO) agents and IO agents plus a vascular
endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) have been …

First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

FSM Monteiro, A Soares, M Debiasi… - Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Combination treatments with immuno-oncology (IO) agents and IO agents plus a vascular
endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) have been …
[PDF] pucrs.br

[PDF][PDF] First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

FSM MONTEIRO, A SOARES… - Clinical …, 2020 - repositorio.pucrs.br
Combination treatments with immuno-oncology (IO) agents and IO agents plus a vascular
endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) have been …

First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis.

FSM Monteiro, A Soares, M Debiasi… - Clinical Genitourinary …, 2020 - europepmc.org
Combination treatments with immuno-oncology (IO) agents and IO agents plus a vascular
endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) have been …

[引用][C] First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

FSM Monteiro, A Soares, M Debiasi, FA Schutz… - Clinical Genitourinary …, 2020 - cir.nii.ac.jp
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era:
Systematic Review and Network Meta-analysis | CiNii Research CiNii 国立情報学研究所 学術 …